Several Indian organisations are trying to block US firm Gilead’s patent claims, which they say will stop the medicine from reaching those who need it the most.

The earliest stage of drug discovery is governed by a simple constraint: there are far more possible drug-like molecules than any pharmaceutical laboratory could ever test. A new deep learning system, ...